Deraco M - Search Results

1

Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.

Brich S, Bozzi F, Perrone F, Tamborini E, Cabras AD, Deraco M, Stacchiotti S, Dagrada GP, Pilotti S. Brich S, et al. Among authors: deraco m. Mod Pathol. 2020 Feb;33(2):217-227. doi: 10.1038/s41379-019-0371-0. Epub 2019 Sep 30. Mod Pathol. 2020. PMID: 31570769 Free article.

2

Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution.

Nonaka D, Kusamura S, Baratti D, Casali P, Cabras AD, Younan R, Rosai J, Deraco M. Nonaka D, et al. Among authors: deraco m. Cancer. 2005 Nov 15;104(10):2181-8. doi: 10.1002/cncr.21239. Cancer. 2005. PMID: 16206294 Free article.

3

Advances in clinical research and management of diffuse peritoneal mesothelioma.

Deraco M, Baratti D, Zaffaroni N, Cabras AD, Kusamura S. Deraco M, et al. Recent Results Cancer Res. 2007;169:137-55. doi: 10.1007/978-3-540-30760-0_13. Recent Results Cancer Res. 2007. PMID: 17506257 No abstract available.

4

Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma.

Zaffaroni N, Costa A, Pennati M, De Marco C, Affini E, Madeo M, Erdas R, Cabras A, Kusamura S, Baratti D, Deraco M, Daidone MG. Zaffaroni N, et al. Among authors: deraco m. Cell Oncol. 2007;29(6):453-66. doi: 10.1155/2007/456839. Cell Oncol. 2007. PMID: 18032822 Free PMC article.

5

Multicystic peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Sironi A, Cabras A, Fumagalli L, Laterza B, Deraco M. Baratti D, et al. Among authors: deraco m. In Vivo. 2008 Jan-Feb;22(1):153-7. In Vivo. 2008. PMID: 18396799 Free article.

6

Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M. Baratti D, et al. Among authors: deraco m. Ann Surg Oncol. 2009 Feb;16(2):463-72. doi: 10.1245/s10434-008-0219-1. Epub 2008 Dec 12. Ann Surg Oncol. 2009. PMID: 19082859

7

Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.

Baratti D, Kusamura S, Nonaka D, Cabras AD, Laterza B, Deraco M. Baratti D, et al. Among authors: deraco m. Ann Surg. 2009 Feb;249(2):243-9. doi: 10.1097/SLA.0b013e31818eec64. Ann Surg. 2009. PMID: 19212177

8

Lymph node metastases in diffuse malignant peritoneal mesothelioma.

Baratti D, Kusamura S, Cabras AD, Laterza B, Balestra MR, Deraco M. Baratti D, et al. Among authors: deraco m. Ann Surg Oncol. 2010 Jan;17(1):45-53. doi: 10.1245/s10434-009-0756-2. Epub 2009 Oct 24. Ann Surg Oncol. 2010. PMID: 19856030

9

Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma.

Perrone F, Jocollè G, Pennati M, Deraco M, Baratti D, Brich S, Orsenigo M, Tarantino E, De Marco C, Bertan C, Cabras A, Bertulli R, Pierotti MA, Zaffaroni N, Pilotti S. Perrone F, et al. Among authors: deraco m. Eur J Cancer. 2010 Oct;46(15):2837-48. doi: 10.1016/j.ejca.2010.06.130. Epub 2010 Aug 6. Eur J Cancer. 2010. PMID: 20692828

10

Experience with peritoneal mesothelioma at the Milan National Cancer Institute.

Deraco M, Baratti D, Cabras AD, Zaffaroni N, Perrone F, Villa R, Jocollè J, Balestra MR, Kusamura S, Laterza B, Pilotti S. Deraco M, et al. World J Gastrointest Oncol. 2010 Feb 15;2(2):76-84. doi: 10.4251/wjgo.v2.i2.76. World J Gastrointest Oncol. 2010. PMID: 21160925 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

227 results

Search Page